Compare Stocks → Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CONENYSE:ELSNYSE:MPWNYSE:NLYNYSE:UDR Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCONECyrusOne$90.36$90.26$66.17▼$90.49$11.71B0.372.84 million shs1 shsELSEquity LifeStyle Properties$61.80+1.2%$65.09$60.47▼$74.04$11.53B0.691.24 million shs1.16 million shsMPWMedical Properties Trust$4.77+3.2%$4.14$2.92▼$10.74$2.86B1.222.98 million shs12.09 million shsNLYAnnaly Capital Management$17.89+1.0%$19.14$14.52▼$21.07$8.95B1.543.62 million shs2.48 million shsUDRUDR$35.34+0.2%$36.49$30.95▼$44.02$11.64B0.82.96 million shs2.42 million shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCONECyrusOne0.00%0.00%0.00%0.00%0.00%ELSEquity LifeStyle Properties-0.46%-4.62%-6.66%-10.60%-7.10%MPWMedical Properties Trust-2.53%+8.20%+5.00%+50.49%-45.84%NLYAnnaly Capital Management-1.75%-8.88%-9.09%-7.11%-8.90%UDRUDR-1.62%-6.87%-5.11%-5.92%-14.54%The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide!MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCONECyrusOneN/AN/AN/AN/AN/AN/AN/AN/AELSEquity LifeStyle Properties3.836 of 5 stars2.13.01.73.02.91.71.9MPWMedical Properties Trust4.0354 of 5 stars3.01.02.53.53.31.71.3NLYAnnaly Capital Management3.5541 of 5 stars2.43.01.72.02.81.71.3UDRUDR4.5116 of 5 stars3.23.04.22.61.51.71.9Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCONECyrusOneN/AN/AN/AN/AELSEquity LifeStyle Properties2.14Hold$70.1513.51% UpsideMPWMedical Properties Trust1.92Reduce$5.7520.55% UpsideNLYAnnaly Capital Management2.83Moderate Buy$21.1918.47% UpsideUDRUDR2.38Hold$41.7118.01% UpsideCurrent Analyst RatingsLatest NLY, UDR, MPW, CONE, and ELS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/17/2024MPWMedical Properties TrustDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeSell ➝ Hold$2.00 ➝ $5.004/10/2024MPWMedical Properties TrustColliers SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$10.00 ➝ $4.254/10/2024UDRUDRPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Neutral$34.00 ➝ $40.004/9/2024UDRUDRTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$45.00 ➝ $42.004/8/2024MPWMedical Properties TrustTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$4.00 ➝ $4.504/2/2024NLYAnnaly Capital ManagementCompass PointSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$22.003/27/2024NLYAnnaly Capital ManagementKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$21.503/26/2024UDRUDRPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight$34.003/4/2024UDRUDRWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$34.00 ➝ $39.003/1/2024MPWMedical Properties TrustBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Outperform$6.002/28/2024UDRUDRMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$38.00 ➝ $35.00(Data available from 4/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCONECyrusOne$1.21B9.71$3.95 per share22.85$22.57 per share4.00ELSEquity LifeStyle Properties$1.49B7.74$2.85 per share21.65$8.04 per share7.69MPWMedical Properties Trust$871.80M3.28$0.13 per share37.64$12.74 per share0.37NLYAnnaly Capital Management$3.73B2.40$3.53 per share5.07$19.61 per share0.91UDRUDR$1.63B7.15$3.40 per share10.38$12.00 per share2.95Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCONECyrusOne$25.30M$0.21430.2920.210.962.10%1.02%0.39%N/AELSEquity LifeStyle Properties$314.21M$1.6836.7920.063.6521.09%20.90%5.62%4/22/2024 (Confirmed)MPWMedical Properties Trust-$556.48M-$0.94N/A4.041.41-2.40%-6.81%-2.92%4/25/2024 (Estimated)NLYAnnaly Capital Management-$1.64B-$3.61N/A6.70N/A-44.03%15.67%1.73%4/24/2024 (Confirmed)UDRUDR$444.35M$1.3426.3713.972.8727.30%11.26%4.02%4/30/2024 (Confirmed)Latest NLY, UDR, MPW, CONE, and ELS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2024N/AUDRUDR$0.61N/A-$0.61N/AN/AN/A 4/24/2024N/ANLYAnnaly Capital Management$0.65N/A-$0.65N/AN/AN/A 4/22/2024N/AELSEquity LifeStyle Properties$0.77$0.49-$0.28N/AN/AN/A DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCONECyrusOne$2.082.30%N/A990.48%N/AELSEquity LifeStyle Properties$1.913.09%+9.32%113.69%N/AMPWMedical Properties Trust$0.6012.58%-1.57%N/A N/ANLYAnnaly Capital Management$2.6014.54%-3.71%N/A N/AUDRUDR$1.704.81%+4.86%126.87%14 YearsLatest NLY, UDR, MPW, CONE, and ELS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/12/2024MPWMedical Properties Trustquarterly$0.1512.8%4/19/20244/22/20245/1/20243/14/2024NLYAnnaly Capital Managementquarterly$0.6513.4%3/27/20243/28/20244/30/20243/14/2024UDRUDRquarterly$0.42504.64%4/9/20244/10/20244/30/20242/6/2024ELSEquity LifeStyle PropertiesQuarterly$0.47702.87%3/27/20243/28/20244/12/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCONECyrusOne1.252.382.38ELSEquity LifeStyle Properties0.350.030.03MPWMedical Properties Trust1.322.262.26NLYAnnaly Capital Management1.401.221.22UDRUDR1.475.155.15OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCONECyrusOne87.89%ELSEquity LifeStyle Properties97.21%MPWMedical Properties Trust71.79%NLYAnnaly Capital Management51.56%UDRUDR97.84%Insider OwnershipCompanyInsider OwnershipCONECyrusOne0.31%ELSEquity LifeStyle Properties1.40%MPWMedical Properties Trust1.22%NLYAnnaly Capital Management0.21%UDRUDR3.73%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCONECyrusOne441129.56 million130.74 millionOptionableELSEquity LifeStyle Properties4,000186.49 million183.88 millionOptionableMPWMedical Properties Trust121599.10 million591.79 millionOptionableNLYAnnaly Capital Management187500.44 million499.39 millionOptionableUDRUDR1,410329.33 million317.05 millionOptionableNLY, UDR, MPW, CONE, and ELS HeadlinesSourceHeadlineDaiwa Securities Group Inc. Acquires 403,377 Shares of UDR, Inc. (NYSE:UDR)marketbeat.com - April 17 at 6:35 PMAirbnb pledges to enable renters to host in their homesshorttermrentalz.com - April 16 at 3:45 PM‘He chose a different route’: Centenarian Troubles survivor Barney O’Dowd laid to restirishtimes.com - April 16 at 3:45 PMBritain should not fear ‘an honest approach’ to past sins, says historianirishtimes.com - April 16 at 3:45 PMWhen nods and winks were enough to get you killed – Mary Kellymsn.com - April 16 at 3:45 PMTroubles pension board overturns decision to withhold payment from Miami Showband survivormsn.com - April 16 at 8:23 AMBomb Kills Mechanicrte.ie - April 14 at 4:04 PMMan jumps to death from Nayandahalli flyover in Bengalurudeccanherald.com - April 13 at 6:27 PMHow a Co Tyrone village became the epicentre of brutal tit-for-tat slaughter in the Troublesbelfasttelegraph.co.uk - April 12 at 3:23 PMCoagh inquest: ‘Kill zone’ set up for men shot dead by SAS in 1991 – solicitormsn.com - April 12 at 3:23 PMWidow of IRA victim reacts to Coagh ambush verdictmsn.com - April 12 at 3:23 PMNisa Investment Advisors LLC Decreases Stock Holdings in UDR, Inc. (NYSE:UDR)marketbeat.com - April 11 at 5:59 AMUDR (NYSE:UDR) Upgraded to "Neutral" by Piper Sandleramericanbankingnews.com - April 11 at 4:58 AMUDR Announces Dates for First Quarter 2024 Earnings Release and Conference Callbusinesswire.com - April 10 at 4:16 PMUDR (NYSE:UDR) Upgraded to Neutral at Piper Sandlermarketbeat.com - April 10 at 8:18 AMUDR (NYSE:UDR) Given New $42.00 Price Target at Truist Financialamericanbankingnews.com - April 10 at 3:26 AMCracking The Code: Understanding Analyst Reviews For UDRmarkets.businessinsider.com - April 9 at 7:04 PMTruist Financial Lowers UDR (NYSE:UDR) Price Target to $42.00marketbeat.com - April 9 at 2:26 PMUDR, Inc. (NYSE:UDR) Receives Consensus Recommendation of "Hold" from Analystsamericanbankingnews.com - April 9 at 2:30 AMUDR, Inc. (NYSE:UDR) Given Average Recommendation of "Hold" by Analystsmarketbeat.com - April 9 at 2:30 AMTravel Routes To Udaipur From Delhi-Mumbai-Kolkata-Bangloremsn.com - April 8 at 1:00 PMMan accused of helping hide body of girlfriend’s daughter sent to jail but could get outmsn.com - April 7 at 8:52 AMIRA victim’s legacy lives on 50 years after his murder, son saysmsn.com - April 5 at 4:13 PMHeadmaster murdered during The Troubles hailed as a ‘special man’uk.news.yahoo.com - April 4 at 9:53 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Key Stocks Helping to Drive the EV RaceApril 12, 2024 9:25 AMView 3 Key Stocks Helping to Drive the EV Race3M Spun Off Its Health Division, Is It Still A Buy?April 4, 2024 7:47 AMView 3M Spun Off Its Health Division, Is It Still A Buy?MarketBeat Week in Review – 3/25-3/29March 30, 2024 7:00 AMView MarketBeat Week in Review – 3/25-3/29Snowflake Stock Gets a Run of Upgrades; is the Low Finally in? March 20, 2024 8:53 AMView Snowflake Stock Gets a Run of Upgrades; is the Low Finally in? 3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1April 9, 2024 7:44 AMView 3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1All Headlines Company DescriptionsCyrusOneNASDAQ:CONECyrusOne, Inc. is a real estate investment trust, which operates and develops enterprise-class, carrier-neutral, multi-tenant, and single-tenant data center properties. The firm provides data center facilities that protect and ensure the continued operation of IT infrastructure. Its data center properties are purpose-built facilities with redundant power, cooling and telecommunications systems that are not network-specific, enabling customer interconnectivity to a range of telecommunications carriers. The company was founded by David H. Ferdman in 2001 and is headquartered in Dallas, TX.Equity LifeStyle PropertiesNYSE:ELSWe are a self-administered, self-managed real estate investment trust (REIT) with headquarters in Chicago. As of January 29, 2024, we own or have an interest in 451 properties in 35 states and British Columbia consisting of 172,465 sites.Medical Properties TrustNYSE:MPWMedical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.Annaly Capital ManagementNYSE:NLYAnnaly Capital Management, Inc., a diversified capital manager, engages in mortgage finance. The company invests in agency mortgage-backed securities collateralized by residential mortgages; non-agency residential whole loans and securitized products within the residential and commercial markets; mortgage servicing rights; agency commercial mortgage-backed securities; to-be-announced forward contracts; residential mortgage loans; and agency or private label credit risk transfer securities. It has elected to be taxed as a real estate investment trust (REIT). As a REIT, it is not subject to federal income tax to the extent that it distributes its taxable income to its shareholders. The company was incorporated in 1996 and is based in New York, New York.UDRNYSE:UDRUDR, Inc. (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate communities in targeted U.S. markets. As of December 31, 2023, UDR owned or had an ownership position in 60,336 apartment homes including 359 homes under development. For over 51 years, UDR has delivered long-term value to shareholders, the best standard of service to Residents and the highest quality experience for Associates. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.